- Home
- GLOB vs PEN Comparison
GLOB vs PEN Comparison
Compare GLOB & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLOB
- PEN
- Stock Information
- Founded
- GLOB 2003
- PEN 2004
- Country
- GLOB Luxembourg
- PEN United States
- Employees
- GLOB N/A
- PEN N/A
- Industry
- GLOB EDP Services
- PEN Medical/Dental Instruments
- Sector
- GLOB Technology
- PEN Health Care
- Exchange
- GLOB Nasdaq
- PEN Nasdaq
- Market Cap
- GLOB 8.7B
- PEN 7.0B
- IPO Year
- GLOB 2014
- PEN 2015
- Fundamental
- Price
- GLOB $193.39
- PEN $195.01
- Analyst Decision
- GLOB Buy
- PEN Buy
- Analyst Count
- GLOB 19
- PEN 14
- Target Price
- GLOB $225.84
- PEN $213.85
- AVG Volume (30 Days)
- GLOB 357.7K
- PEN 374.1K
- Earning Date
- GLOB 11-14-2024
- PEN 10-30-2024
- Dividend Yield
- GLOB N/A
- PEN N/A
- EPS Growth
- GLOB 10.97
- PEN N/A
- EPS
- GLOB 3.83
- PEN 0.37
- Revenue
- GLOB $2,284,526,000.00
- PEN $1,133,683,000.00
- Revenue This Year
- GLOB $17.51
- PEN $13.37
- Revenue Next Year
- GLOB $15.59
- PEN $14.75
- P/E Ratio
- GLOB $51.32
- PEN $530.20
- Revenue Growth
- GLOB 19.01
- PEN 20.89
- 52 Week Low
- GLOB $151.68
- PEN $148.00
- 52 Week High
- GLOB $251.50
- PEN $277.34
- Technical
- Relative Strength Index (RSI)
- GLOB 46.66
- PEN 51.56
- Support Level
- GLOB $194.50
- PEN $186.97
- Resistance Level
- GLOB $200.51
- PEN $194.55
- Average True Range (ATR)
- GLOB 5.19
- PEN 6.30
- MACD
- GLOB -0.04
- PEN -0.15
- Stochastic Oscillator
- GLOB 36.49
- PEN 54.56
About GLOB Globant S.A.
Globant SA is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the U.S. and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.